Three-dimensional, but not two-dimensional, culture results in tumor growth enhancement after exposure to anticancer drugs

Kobe Journal of Medical Sciences

Volumn 53, Issue 6, 2007, Pages 335-343

  Komoto, Chiho ^a   Nakamura, Tsutomu ^a   Ohmoto, Nobuko ^a   Kobayashi, Hironao ^b   Yagami, Tatsurou ^b   Nishiguchi, Kohshi ^a   Iwaki, Koichi ^a   Kuwahara, Akiko ^a   Yamamori, Motohiro ^a   Okamura, Noboru ^c   Okumura, Katsuhiko ^a,c   Sakaeda, Toshiyuki ^d  

^a KOBE UNIVERSITY   (Japan)

^b SHIONOGI AND CO LTD   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

CD DST; Chemosensitivity; Growth enhancement; MDR1; P glycoprotein

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ANTINEOPLASTIC AGENT; CISPLATIN; COLLAGEN GEL; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; GLYCOPROTEIN P; IRINOTECAN; METHOTREXATE; MITOMYCIN C; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; VINDESINE;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CELL ASSAY; CELL CULTURE; CHEMOSENSITIVITY; COLLAGEN GEL DROPLET EMBEDDED CULTURE DRUG SENSITIVITY TEST; COLORECTAL CANCER; EMBEDDING; HELA CELL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; THREE DIMENSIONAL IMAGING; TUMOR GROWTH; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; NEOPLASMS;

EID: 45749099602     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bogden, A.E., Griffin, W., Reich, S.D., Costanza, M.E. and Cobb, W.R. 1984. Predictive testing with the subrenal capsule assay. Cancer Treatment Rev. 11 (supplement A): 113-124.
2. Carmichael, J., DeGraff, W.G., Gazdar, A.F., Minna, J.D. and Mitchell, J.B. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47: 936-942.
3. Cho, S.R., Ock, S.A., Yoo, J.G., Mohana Kumar, B., Choe, S.Y. and Rho, G.J. 2005. Effects of confluent, roscovitine treatment and serum starvation on the cell-cycle synchronization of bovine foetal fibroblasts. Reprod. Domest. Anim. 40: 171-176.
4. Freeman, A.E. and Hoffman, R.M. 1986. In vivo-like growth of human tumors in vitro. Proc. Natl. Acad. Sci. U.S.A. 83: 2694-2698.
5. Hoffman, R.M. 1994. The three-dimensional question: can clinically relevant tumor drug resistance be measured in vitro? Cancer Metastasis Rev. 13: 169-173.
6. Iida, N., Takara, K., Ohmoto, N., Nakamura, T., Kimura, T., Wada, A., Hirai, M., Sakaeda, T. and Okumura, K. 2001. Reversal effects of antifungal drugs on multidrug resistance in MDR1-overexpressing HeLa cells. Biol. Pharm. Bull. 24: 1032-1036.
7. Kern, D.H., Drogemuller, C.R., Kennedy, M.C., Hildebrand-Zanki, S.U., Tanigawa, N. and Sondak, V.K. 1985. Development of a miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors. Cancer Res. 45: 5436-5441.
8. Kobayashi, H., Tanisaka, K., Doi, O., Kodama, K., Higashiyama, M., Nakagawa, H., Miyake, M., Taki, T., Hara, S., Yasutomi, M., Hanatani, Y., Kotake, K. and Kubota, T. 1997. An in vitro chemosensitivity test for solid human tumors using collagen gel droplet embedded cultures. Int. J. Oncol. 11: 449-455.
9. Kobayashi, H., Higashiyama, M., Minamigawa, K., Tanisaka, K., Takano, T., Yokouchi, H., Kodama, K. and Hata, T. 2001. Examination of in vitro chemosensitivity test using collagen gel droplet culture method with colorimetric endpoint quantification. Jpn. J. Cancer Res. 92: 203-210.
10. Kobayashi, H. 2003. Development of a new in vitro chemosensitivity test using collagen gel droplet embedded culture and image analysis for clinical usefulness. Recent Results. Cancer Res. 161: 48-61.
11. Kondo, T., Imamura, T. and Ishihashi, H. 1966. In vitro test for sensitivity of tumor to carcinostatic agents. Jpn. J. Cancer Res. (Gann) 57: 113-121.
12. Kubota, T., Sasano, N., Abe, O., Nakao, I., Kawamura, E., Saito, T., Endo, M., Kimura, K., Demura, H., Sasano, H., Nagura, H., Ogawa, N. and Hoffman, R.M. 1995. Potential of the histoculture drug-response assay to contribute to cancer patient survival. Clin. Cancer Res. 1: 1537-1543.
13. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63.
14. Nagai, N., Minamikawa, K., Mukai, K., Hirata, E., Komatsu, M. and Kobayashi, H. 2005. Predicting the chemosensitivity of ovarian and uterine cancers with the collagen gel droplet culture drug-sensitivity test. Anticancer Drugs 16: 525-531.
15. Nakahara, T., Sakaeda, T., Nakamura, T., Tamura, T., Nishioka, C., Aoyama, N., Okamura, N., Shirakawa, T., Gotoh, A., Kamigaki, T., Ohno, M., Kuroda, Y., Matsuo, M., Kasuga, M. and Okumura, K. 2004. Chemosensitivity assessed by collagen gel droplet embedded culture drug sensitivity test, and MDR1, MRP1, and MRP2 mRNA expression in human colorectal adenocarcinomas. Pharm. Res. 21: 406-412.
16. Nishioka, C., Sakaeda, T., Nakamura, T., Moriya, Y., Okamura, N., Tamura, T., Nakahara, T., Aoyama, N., Kamigaki, T., Ohno, M., Kuroda, Y., Kasuga, M. and Okumura, K. 2004. MDR1, MRP1 and MRP2 genotypes and in vitro chemosensitivity in Japanese patients with colorectal adenocarcinomas. Kobe J. Med. Sci. 50: 181-188.
17. Rozencweig, M., Hofmann, V., Sanders, C., Rombaut, W., Fruh, U. and Martz, G. 1984. In vitro growth of human malignancies in a cloning assay. Recent Results Cancer Res. 94: 1-7.
18. Sakaeda, T., Nakamura, T. and Okumura, K. 2002. MDR1 genotype-related pharmacokinetics and pharmacodynamics. Biol. Pharm. Bull. 25: 1391-1400.
19. Sakaeda, T., Nakamura, T. and Okumura, K. 2003. Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs. Pharmacogenomics 4: 397-410.
20. Salmon, S.E., Hamburger, A.W., Soehnlen, B., Durie, B.G.M., Alberts, D.S. and Moon, T.E. 1978. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N. Engl. J. Med. 298: 1321-1327.
21. Takara, K., Sakaeda, T., Yagami, T., Kobayashi, H., Ohmoto, N., Horinouchi, M., Nishiguchi, K. and Okumura, K. 2002. Cytotoxic effects of 27 anticancer drugs in HeLa and MDR1-overexpressing derivative cell lines. Biol. Pharm. Bull. 25: 771-778.
22. Tanigawa, N., Kern, D.H., Hikasa, Y. and Morton, D.L. 1982. Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture. Cancer Res. 42: 2159-2164.
23. Vescio, R.A., Redfern, C.H., Nelson, T.J., Ugoretz, S., Stern, P.H. and Hoffman, R.M. 1987. In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. Proc. Natl. Acad. Sci. U.S.A. 84: 5029-5033.
24. von Hoff, D.D., Cowan, J., Harris, G. and Reisdorf, G. 1981. Human tumor cloning: feasibility and clinical correlations. Cancer Chemother. Pharmacol. 6: 265-271.
25. Yasuda, H., Takada, T., Wada, K., Amano, H., Isaka, T., Yoshida, M., Uchida, T. and Toyota, N. 1998. A new in-vitro drug sensitivity test (collagen-gel droplet embedded-culture drug sensitivity test) in carcinomas of pancreas and biliary tract: possible clinical utility. J. Hepatobiliary Pancreat. Surg. 5: 261-268.